Abstract:Familial combined hyperlipidemia (FCHL) is a common lipid disorder characterized by the presence of multiple lipoprotein phenotypes that increase the risk of premature coronary heart disease. In a previous study, we identiWed an intragenic microsatellite marker within the protocadherin 15 (PCDH15) gene to be associated with high triglycerides (TGs) in Finnish dyslipidemic families. In this study we analyzed all four known nonsynonymous SNPs within PCDH15 in 1,268 individuals from Finnish and Dutch multigenerat… Show more
“…Thus, our findings are consistent with the growing evidence that specialized lipid microdomains may play a critical role in hair cell functions. On a pragmatic level, recent reports have associated hyperlipidemia and dyslipidemia with hearing loss (47,48). The findings that outer hair cell function is tuned to membrane cholesterol content (49,17) further strengthens the growing evidence suggesting that membrane lipid microdomains may be important for hair cell physiology and pathophysiology.…”
“…Thus, our findings are consistent with the growing evidence that specialized lipid microdomains may play a critical role in hair cell functions. On a pragmatic level, recent reports have associated hyperlipidemia and dyslipidemia with hearing loss (47,48). The findings that outer hair cell function is tuned to membrane cholesterol content (49,17) further strengthens the growing evidence suggesting that membrane lipid microdomains may be important for hair cell physiology and pathophysiology.…”
“…Rs10825036 is close to the PCDH15 gene which encodes integral membrane proteins that mediate calcium-dependent cell-cell adhesion. Previously, the SNPs of the PCDH15 gene are known for associations with adverse events caused by chemotherapy in breast cancer[ 49 ] as well as with lipid abnormalities[ 50 ]. The lipid profiles have been associated with the risk, stage, and recurrence of breast cancer[ 51 – 53 ].…”
PurposeTo identify the genetic variants associated with breast cancer survival, a genome-wide association study (GWAS) was conducted of Korean breast cancer patients.MethodsFrom the Seoul Breast Cancer Study (SEBCS), 3,226 patients with breast cancer (1,732 in the discovery and 1,494 in the replication set) were included in a two-stage GWAS on disease-free survival (DFS) by tumor subtypes based on hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2). The associations of the re-classified combined prognostic markers through recursive partitioning analysis (RPA) of DFS for breast cancer were assessed with the Cox proportional hazard model. The prognostic predictive values of the clinical and genetic models were evaluated by Harrell’s C.ResultsIn the two-stage GWAS stratified by tumor subtypes, rs166870 and rs10825036 were consistently associated with DFS in the HR+ HER2- and HR- HER2- breast cancer subtypes, respectively (P
rs166870=2.88×10-7 and P
rs10825036=3.54×10-7 in the combined set). When patients were classified by the RPA in each subtype, genetic factors contributed significantly to differentiating the high risk group associated with DFS inbreast cancer, specifically the HR+ HER2- (P
discovery=1.18×10-8 and P
replication=2.08×10-5) and HR- HRE2- subtypes (P
discovery=2.35×10-4 and P
replication=2.60×10-2). The inclusion of the SNPs tended to improve the performance of the prognostic models consisting of age, TNM stage and tumor subtypes based on ER, PR, and HER2 status.ConclusionCombined prognostic markers that include clinical and genetic factors by tumor subtypes could improve the prediction of survival in breast cancer.
“…Mutations in PCDH15 result in hearing loss and Usher syndrome type 1F (USH1F) 19,20 . SNPs in this gene have also been found to be associated with lipid abnormalities 21 and immune response to smallpox vaccine 22 . During the embryonic stage in mice, Pcdh15 is highly expressed in Rathke's pouch, which ultimately develops into the pituitary 23 .…”
Pituitary adenoma is one of the most common intracranial neoplasms, and its genetic basis remains largely unknown. To identify genetic susceptibility loci for sporadic pituitary adenoma, we performed a three-stage genome-wide association study (GWAS) in the Han Chinese population. We first analyzed genome-wide SNP data in 771 pituitary adenoma cases and 2,788 controls and then carried forward the promising variants for replication in another 2 independent sets (2,542 cases and 3,620 controls in total). We identified three new susceptibility loci below the genome-wide significance threshold (P < 5 × 10(-8)) in the combined analyses: 10p12.31 (rs2359536, P(meta) = 2.25 × 10(-10) and rs10828088, P(meta) = 6.27 × 10(-10)), 10q21.1 (rs10763170, P(meta) = 6.88 × 10(-10)) and 13q12.13 (rs17083838, P(meta) = 1.89 × 10(-8)). This study is the first GWAS to our knowledge on sporadic pituitary adenoma, and our results provide insight into the genetic basis of this disease.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.